Showing results (501-510 of 542) with videos related to

Sort By:
Pageof 55
Nature Communications|January 12, 2023
Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trialSten M M van Beek, Yvonne M H Bruls, Froukje Vanweert, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2024
The Plasma Lipidomic Landscape in Patients with Sepsis due to Community-acquired PneumoniaOsoul Chouchane, Alex R Schuurman, Tom D Y Reijnders, et al.
Human Mutation|May 7, 2019
Mutations in TIMM50 cause severe mitochondrial dysfunction by targeting key aspects of mitochondrial physiologyFrederic Tort, Olatz Ugarteburu, Laura Texidó, et al.
Journal of Cellular Biochemistry|January 16, 2026
HEPES in Cell Culture Alters the Multi-Omics Profile Exhibited by Gaucher Disease FibroblastsEleonore M Corazolla, Bauke V Schomakers, Maria M Trętowicz, et al.
ESMO Open|September 10, 2024
Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trialM Vaz Batista, J M Pérez-García, P Cortez, et al.
Stem Cell Research|July 14, 2019
Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patientFernanda Gubert, Juliana F Vasques, Tatiane D Cozendey, et al.
Journal of Inherited Metabolic Disease|October 18, 2022
Sex-specific newborn screening for X-linked adrenoleukodystrophyMonique Albersen, Samantha L van der Beek, Inge M E Dijkstra, et al.
ESMO Open|January 4, 2025
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasisR Bartsch, J M Pérez-García, J Furtner, et al.
Brain Communications|September 21, 2020
Deep phenotyping classical galactosemia: clinical outcomes and biochemical markersMendy M Welsink-Karssies, Sacha Ferdinandusse, Gert J Geurtsen, et al.
Stem Cell Research|August 13, 2018
Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relativesT H Kasai-Brunswick, D Silva Dos Santos, R P Ferreira, et al.
Pageof 55